We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This paper sets out the CMA’s key findings from its programme of work on vulnerable consumers.
Employment Tribunal decision.
This document contains the following information: Buying Solutions annual report and accounts 2009 to 2010.
A lesson in exceeding the original concept: The journey of Createc's LiDAR autonomous crowd monitoring solution, purchased by Network Rail
Decision for applicant Barclays Bank UK PLC registration number 14752651, applicant successful.
This consultation seeks views on a pragmatic, flexible way to help house builders meet the zero carbon homes standard by reducing some carbon emissions ‘off-site’.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Sun Pharma UK Ltd has informed the MHRA of a labelling issue with one batch of Gemcitabine 2000mg/200ml infusion.
An Environment Agency fisheries team has transformed a weir on the River Thames to allow eels to get past it and swim upstream.
Joint UK-US statement on Climate Finance Mobilisation Forum that encouraged philanthropists and financiers to increase support for emerging markets and developing countries in tackling the climate crisis.
First published during the 2022 to 2024 Sunak Conservative government
Decision for applicant FXPro Financial Services Ltd registration number 14847581, applicant successful.
Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).